Pharmacokinetics and biotransformation of the prostacyclin analogue, ZK 36 374 I. Synthesis of a tritium marker and excretion of [3H]-ZK 36 374 in the rat

This publication has 13 references indexed in Scilit:

• Carbacyclin — A potent stable prost acyclin analogue for the inhibition of platelet aggregation
  Prostaglandins, 1980
• Metabolism of two PGF2α analogues in primates: 15(S)-15-methyl-Δ4--PGF1α and 16,16-dimethyl-Δ4--PGF1α
  Prostaglandins, 1979
• Comparison between the in vivo rate of metabolism of prostaglandin I2 and its blood-pressure-lowering response after intravenous administration in the rat
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
• Metabolism of prostacyclin in rat
  Biochemistry, 1978
• Pulmonary metabolism of prostacyclin (PGI2) in the rabbit
  Biochemical and Biophysical Research Communications, 1978
• Prostacyclin (PGX) is the endogeneous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid
  Prostaglandins, 1977
• HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
  The Lancet, 1977
• The chemical structure of prostaglandin X (prostacyclin)
  Prostaglandins, 1976
• A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
  Prostaglandins, 1976